Background: Current Australian mental health policy recommends that carers should
medication. Carers commonly addressed the shortfall in information by obtaining additional information through online sources or carer networks. Almost all carers emphasized that they should be involved in decisions about antipsychotic medication, but noted that they were typically excluded. The lack of involvement in medication decisions was a source of frustration, as carers could contribute saliently through sharing detailed knowledge about mental health consumers' lives, address communication gaps and improve communication between health professionals and consumers.
| BACKGROUND
Carer involvement in service delivery has been recognized as an integral component of mental health care. 1, 2 The increased emphasis on carer participation has to some extent been driven by the shift away from hospitals towards primarily providing mental health treatment in the community, wherein carers are more extensively engaged in supporting consumers. 3 The development of antipsychotic medication and its subsequent use as the cornerstone of treatment for severe mental illness has been one of the factors behind the increase in delivering mental health care in the community. 4 Given their involvement in the recovery of mental health consumers, carers may gain important insight into the effect of antipsychotic medication on consumers' lives and make a valuable contribution to well-informed decisions about the use of medication.
The adverse impact of antipsychotic medication on mental health consumers' lives will also probably be a significant concern for their carers, especially as the side-effects often impair physical and social functioning, and carers therefore will have an important role in assisting consumers with daily activities. [5] [6] [7] [8] [9] To our knowledge, though, no prior research has explored carers' involvement in decision making about antipsychotic medication specifically. However, other facets of caregiving for mental health consumers have been detailed in several previous studies, which inform the context of this study.
Studies have consistently demonstrated that carers of mental health consumers experience elevated levels of burden and mental distress, and impaired quality of life. [10] [11] [12] [13] Moreover, recent Australian research reported that almost half of mental health consumer caregivers satisfied criteria for probable psychiatric disorders and were ten times more likely to experience social isolation than other community groups. 3 Carers often note that mental health services are not meeting consumers' basic needs, which evokes anguish in carers and increases burden. 4 In addition, carers of mental health consumers commonly report that health professionals do not provide information or advice about the anticipated course of mental illness or mental health care in general, which are also sources of significant distress. [14] [15] [16] In summary, the extant literature reports important details about distress and burden among carers of mental health consumers. The literature notably omits studies that explore carers' involvement in decisions made about mental health consumers' antipsychotic medication regimes. It is important to develop an understanding of carer involvement in such decisions as they often have detailed insight into the lives of mental health consumers and could contribute valuable information about the effect of medication. The aim of this study therefore was to explore carers' participation in antipsychotic medication decision making.
| METHODS
A narrative approach was used to guide the conduct of the interviews in this study. 17 This approach seeks to elicit from the interviewee information about important events and the context in which they occurred. The interviewer aims to exert little influence over the elicited narrative, because the interview's main purpose is to understand social events in terms of the informant's perspective. As such, the narrative approach was well suited for this study, as we sought to authentically reflect the experience of a group of people whose voices have often been marginalized by health professionals and the highly structured care systems in which they work.
| Recruitment
Carers of mental health consumers who took antipsychotic medication were enrolled in this study through the use of snowball sampling. 18 Potential participants were initially identified from the personal contacts of a caregiver who expressed interest in a prior study that we had undertaken. In addition, contact details for potential participants, who had declared interest in sharing their experience, were sourced from an advocacy service. Finally, invitation notices were disseminated through social media and email lists by several carer organizations.
| Ethics
The Murdoch University Human Research Ethics Committee granted ethical approval for this study (2015/039). All participants confirmed that they had read the information letter and provided written informed consent prior to the commencement of each interview. Pseudonyms were assigned to all participants to maintain confidentiality.
| Data collection
Semi-structured individual interviews were the principal means through which data were collected, although in two instances, family member pairs were interviewed at the same time, and a single focus group was conducted with a carer support group. All interviews were undertaken by a research assistant, who used recommendations that were developed to promote consumer participation. 19 
| Data analysis
All interviews and focus group recordings were transcribed verbatim.
Thematic analysis was used to analyse the data. 20 The analysis was mainly focused on delineating broad themes in the textual data sets. An inductive data-driven process was used to generate the themes, through which the themes were tightly linked to the data and predominantly remained at the semantic level. 20 All aspects of the data reflected views about the provision of information and involvement in decision making about antipsychotic medication and were coded to explore the manner in which the experience was embodied in each account. The analysis began with line-by-line coding, which consisted of considering each line of data on an individual basis, and assigning initial codes that explained small sections of the data. 21 Next, focussed codes were constructed by combining similar initial codes through the use of constant comparison analysis. 21 Particularly incisive codes were grouped into preliminary themes and then reiteratively synthesized into overarching themes.
| FINDINGS
The thematic analysis resulted in the identification of four principal themes that provide a rich narrative of carers' participation in antip- 
| Participant characteristics
In total, 29 carers were enrolled in this study, of which 19 participated in semi-structured interviews, and 10 participated in a focus group. Most carers were female and typically cared for male mental health consumers. In about three quarters of the cases, carers supported people with a diagnosis of either schizophrenia or schizoaffective disorder.
| Receiving information about antipsychotic medication
Participation in decision making depends on the provision, acquisition and understanding of relevant information about medications that enables people to make informed decisions. However, most carers noted that they had been provided with little or no information about antipsychotic medication from the treatment team: 
[Paul 97-98]
Several carers stated that they had received detailed information, but even then there were reservations about the manner in which the information was presented and the stressful context in which it was provided:
There was always consultation with the psychiatrist. 
| Independently gathering information about antipsychotic medication
The failure to provide information to carers or the unsuitability of the information that was provided prompted most carers to independently source information about antipsychotic medication and mental illness. This initiative was necessary to compensate for the shortfall in appropriate information provided by health professionals. In a minority of the cases, carers did not actively seek out information because the medication was effective: 
| Exclusion from decisions about antipsychotic medication
Most carers emphasized that they should be involved in medication decisions but that they were also typically excluded from decision making: "I have not been involved in anything to do with his medication with any psychiatrists because they won't talk to me" [Angela 
| Contributing to enhanced decision making about antipsychotic medication
Several carers noted that they could improve decision making through providing information that consumers may be unable to disclose perhaps because they do not wish to or because they are unwell: 
[Irene 48-53]
The manner in which medication-related information was provided to mental health consumers was also an aspect of communication that carers felt could be improved. In particular, carers voiced concern that health professionals did not clearly communicate the most typical medication effects and that carers could assist in clarifying these issues for consumers: 
| DISCUSSION
The carers in this study typically reported that they had received Mental health consumers and health professionals typically express interest in collaborative decision making. 22, 23 Yet health professionals commonly state that they do not include mental health consumers in decisions because of a perceived lack of capacity. 22, 23 The findings of the present study demonstrate that exclusion from decision making also extends to carers of mental health consumers, who have the right to be involved in decision making and clearly have the capacity to make worthwhile contributions. 1, 2 The exclusion of carers and consumers suggests that the prevailing culture in mental health services may be controlling, certainly in relation to the experiences of the participants in this location. Hence, mental health services may need to reassess the extent to which consumers, and especially carers, could be more effectively included in decision making with respect to the prescription, delivery and evaluation of antipsychotic medication.
The importance that carers placed on being involved in decision making about antipsychotic medication mirrors the call in the most recent National Mental Plan for enhanced participation of carers in the provision of mental health services. 2 Recommendations alone, however, are not adequate and formal structures and processes may need to be implemented to ensure that the level of carer engagement is appropriate for the individual needs of both consumers and carers. provide to consumers, sometimes in an on-going way when medication is recommended for long periods of time. In summary, it would be worthwhile to conduct further studies to develop and workshop information that presents the most likely beneficial and adverse affects of antipsychotic medication, and the types of strategies needed to support mental health consumers as they deal with the consequences of these medications.
In some instances, mental health consumers may have concerns about the extent to which their families are involved in mental health-care decision making. These concerns, though, can usually be accommodated through using communication processes that enable respectful family participation. 29 This approach to fostering family involvement is based on the use of release forms that specifically detail information that health professionals can share with families. 30 It may be the case that some mental health consumers do not want health professionals to provide any information to their families. However, health professionals are only obliged to not disclose confidential information and can consider what types of information could be given to families without breaching confidentiality. Such non-confidential material can include basic information about mental illness, which may include aetiology, general prognoses, warning signs and symptoms, and standard treatment plans. 30 
| LIMITATIONS
The findings presented here reflect the experience of a moderate number of caregivers, who reside in a single Australian state. Also, the sample was self-selected and may have had a particular interest in the researched area. Our results therefore should be viewed carefully as the material might not be representative of carers' perspectives in general. Nonetheless, the findings of this study provide a rich, novel description of diverse carer views in regard to the use of antipsychotic medication, which may be of benefit to health professionals in informing the delivery of mental health care.
| CONCLUSION
This study builds an understanding of the carers' role when supporting mental health consumers who take antipsychotic medication; their concerns about information and decision making, the sense of exclusion and missed opportunity to contribute usefully to the care process in a collaborative way. Overall, the findings demonstrate the health professionals need to substantially improve the extent to which they collaborate with carers in medication decisions, especially as current Australian mental health policy mandates the involvement of carers in the delivery of services to mental health consumers. Carers often provide essential, intensive support to mental health consumers during recovery, and therefore, their views and experiences should be an integral component of the assessment and production of treatment and health-care services. Further, gaining a more detailed appreciation about carers' lives will assist health professionals to develop appropriate approaches to support carers as they walk alongside mental health consumers in the recovery journey.
